Submit Feedback
Learn more about Cencora's Revenue by Segment and Revenue by Region.
Check out competitors to Cencora in a side-by-side comparison.
Explore additional financial metrics for Cencora.
| 2015 | 135961803000.00 |
|---|---|
| 2016 | 146849686000.00 |
| 2017 | 153143826000.00 |
| 2018 | 167939635000.00 |
| 2019 | 179589121000.00 |
| 2020 | 189893926000.00 |
| 2021 | 213988843000.00 |
| 2022 | 238587006000.00 |
| 2023 | 262173411000.00 |
| 2024 | 293958599000.00 |
| 2025 | 321332819000.00 |
| Mar 2016 | 35698357000.00 |
|---|---|
| Jun 2016 | 36881680000.00 |
| Sep 2016 | 37560603000.00 |
| Dec 2016 | 38169265000.00 |
| Mar 2017 | 37147402000.00 |
| Jun 2017 | 38707144000.00 |
| Sep 2017 | 39120015000.00 |
| Dec 2017 | 40466332000.00 |
| Mar 2018 | 41033858000.00 |
| Jun 2018 | 43142309000.00 |
| Sep 2018 | 43297136000.00 |
| Dec 2018 | 45392452000.00 |
| Mar 2019 | 43319602000.00 |
| Jun 2019 | 45239265000.00 |
| Sep 2019 | 45637802000.00 |
| Dec 2019 | 47864742000.00 |
| Mar 2020 | 47417639000.00 |
| Jun 2020 | 45366777000.00 |
| Sep 2020 | 49244768000.00 |
| Dec 2020 | 52516556000.00 |
| Mar 2021 | 49154171000.00 |
| Jun 2021 | 53405695000.00 |
| Sep 2021 | 58912421000.00 |
| Dec 2021 | 59628810000.00 |
| Mar 2022 | 57719446000.00 |
| Jun 2022 | 60064601000.00 |
| Sep 2022 | 61174149000.00 |
| Dec 2022 | 62846832000.00 |
| Mar 2023 | 63457205000.00 |
| Jun 2023 | 66947043000.00 |
| Sep 2023 | 68922331000.00 |
| Dec 2023 | 72252833000.00 |
| Mar 2024 | 68414307000.00 |
| Jun 2024 | 74241353000.00 |
| Sep 2024 | 79050106000.00 |
| Dec 2024 | 81487060000.00 |
| Mar 2025 | 75453673000.00 |
| Jun 2025 | 80663532000.00 |
| Sep 2025 | 83728554000.00 |
| Dec 2025 | 85932016000.00 |
| Mar 2026 | 78355916000.00 |
| Jun 2026 | 84754837000.00 |
Cencora's annual revenue was $321.33 B in fiscal year 2025.
Cencora's quarterly revenue was $81.49 B(Q1: Dec 2024), $75.45 B(Q2: Mar 2025), $80.66 B(Q3: Jun 2025), $83.73 B(Q4: Sep 2025) in fiscal year 2025.
Cencora's annual revenue was $293.96 B in fiscal year 2024.
Cencora's quarterly revenue was $72.25 B(Q1: Dec 2023), $68.41 B(Q2: Mar 2024), $74.24 B(Q3: Jun 2024), $79.05 B(Q4: Sep 2024) in fiscal year 2024.
Cencora's annual revenue was $262.17 B in fiscal year 2023.
Cencora's quarterly revenue was $62.85 B(Q1: Dec 2022), $63.46 B(Q2: Mar 2023), $66.95 B(Q3: Jun 2023), $68.92 B(Q4: Sep 2023) in fiscal year 2023.
Cencora's annual revenue was $238.59 B in fiscal year 2022.
Cencora's quarterly revenue was $59.63 B(Q1: Dec 2021), $57.72 B(Q2: Mar 2022), $60.06 B(Q3: Jun 2022), $61.17 B(Q4: Sep 2022) in fiscal year 2022.
Cencora's annual revenue was $213.99 B in fiscal year 2021.
Cencora's quarterly revenue was $52.52 B(Q1: Dec 2020), $49.15 B(Q2: Mar 2021), $53.41 B(Q3: Jun 2021), $58.91 B(Q4: Sep 2021) in fiscal year 2021.
Cencora's annual revenue was $189.89 B in fiscal year 2020.
Cencora's quarterly revenue was $47.86 B(Q1: Dec 2019), $47.42 B(Q2: Mar 2020), $45.37 B(Q3: Jun 2020), $49.24 B(Q4: Sep 2020) in fiscal year 2020.
Cencora's annual revenue was $179.59 B in fiscal year 2019.
Cencora's quarterly revenue was $45.39 B(Q1: Dec 2018), $43.32 B(Q2: Mar 2019), $45.24 B(Q3: Jun 2019), $45.64 B(Q4: Sep 2019) in fiscal year 2019.
Cencora's annual revenue was $167.94 B in fiscal year 2018.
Cencora's quarterly revenue was $40.47 B(Q1: Dec 2017), $41.03 B(Q2: Mar 2018), $43.14 B(Q3: Jun 2018), $43.30 B(Q4: Sep 2018) in fiscal year 2018.
Cencora's annual revenue was $153.14 B in fiscal year 2017.
Cencora's quarterly revenue was $38.17 B(Q1: Dec 2016), $37.15 B(Q2: Mar 2017), $38.71 B(Q3: Jun 2017), $39.12 B(Q4: Sep 2017) in fiscal year 2017.
Cencora's annual revenue was $146.85 B in fiscal year 2016.
Cencora's quarterly revenue was $36.71 B(Q1: Dec 2015), $35.70 B(Q2: Mar 2016), $36.88 B(Q3: Jun 2016), $37.56 B(Q4: Sep 2016) in fiscal year 2016.
| 2015 | 0 |
|---|---|
| 2016 | +8.01 |
| 2017 | +4.29 |
| 2018 | +9.66 |
| 2019 | +6.94 |
| 2020 | +5.74 |
| 2021 | +12.69 |
| 2022 | +11.50 |
| 2023 | +9.89 |
| 2024 | +12.12 |
| 2025 | +9.31 |
| Q1: Dec 15 | 9.29 |
|---|---|
| Q2: Mar 16 | 9.27 |
| Q3: Jun 16 | 7.74 |
| Q4: Sep 16 | 5.89 |
| Q1: Dec 16 | 3.98 |
| Q2: Mar 17 | 4.06 |
| Q3: Jun 17 | 4.95 |
| Q4: Sep 17 | 4.15 |
| Q1: Dec 17 | 6.02 |
| Q2: Mar 18 | 10.46 |
| Q3: Jun 18 | 11.46 |
| Q4: Sep 18 | 10.68 |
| Q1: Dec 18 | 12.17 |
| Q2: Mar 19 | 5.57 |
| Q3: Jun 19 | 4.86 |
| Q4: Sep 19 | 5.41 |
| Q1: Dec 19 | 5.45 |
| Q2: Mar 20 | 9.46 |
| Q3: Jun 20 | 0.28 |
| Q4: Sep 20 | 7.90 |
| Q1: Dec 20 | 9.72 |
| Q2: Mar 21 | 3.66 |
| Q3: Jun 21 | 17.72 |
| Q4: Sep 21 | 19.63 |
| Q1: Dec 21 | 13.54 |
| Q2: Mar 22 | 17.43 |
| Q3: Jun 22 | 12.47 |
| Q4: Sep 22 | 3.84 |
| Q1: Dec 22 | 5.40 |
| Q2: Mar 23 | 9.94 |
| Q3: Jun 23 | 11.46 |
| Q4: Sep 23 | 12.67 |
| Q1: Dec 23 | 14.97 |
| Q2: Mar 24 | 7.81 |
| Q3: Jun 24 | 10.90 |
| Q4: Sep 24 | 14.69 |
| Q1: Dec 24 | 12.78 |
| Q2: Mar 25 | 10.29 |
| Q3: Jun 25 | 8.65 |
| Q4: Sep 25 | 5.92 |
| Q1: Dec 25 | 5.45 |
| Q2: Mar 26 | 3.85 |
| Q3: Jun 26 | 5.07 |
Cencoraโs annual revenue increased +9.31% during fiscal year 2025 compared to 2024. It represents a growth of $27.37 B from $293.96 B (in 2024) to $321.33 B (in 2025).
Cencoraโs annual revenue increased +12.12% during fiscal year 2024 compared to 2023. It represents a growth of $31.79 B from $262.17 B (in 2023) to $293.96 B (in 2024).
Cencoraโs annual revenue increased +9.89% during fiscal year 2023 compared to 2022. It represents a growth of $23.59 B from $238.59 B (in 2022) to $262.17 B (in 2023).
Cencoraโs annual revenue increased +11.50% during fiscal year 2022 compared to 2021. It represents a growth of $24.60 B from $213.99 B (in 2021) to $238.59 B (in 2022).
Cencoraโs annual revenue increased +12.69% during fiscal year 2021 compared to 2020. It represents a growth of $24.09 B from $189.89 B (in 2020) to $213.99 B (in 2021).
Cencoraโs annual revenue increased +5.74% during fiscal year 2020 compared to 2019. It represents a growth of $10.30 B from $179.59 B (in 2019) to $189.89 B (in 2020).
Cencoraโs annual revenue increased +6.94% during fiscal year 2019 compared to 2018. It represents a growth of $11.65 B from $167.94 B (in 2018) to $179.59 B (in 2019).
Cencoraโs annual revenue increased +9.66% during fiscal year 2018 compared to 2017. It represents a growth of $14.80 B from $153.14 B (in 2017) to $167.94 B (in 2018).
Cencoraโs annual revenue increased +4.29% during fiscal year 2017 compared to 2016. It represents a growth of $6.29 B from $146.85 B (in 2016) to $153.14 B (in 2017).
Cencoraโs annual revenue increased +8.01% during fiscal year 2016 compared to 2015. It represents a growth of $10.89 B from $135.96 B (in 2015) to $146.85 B (in 2016).
| Period | Revenue | Year-over-Year Change |
|---|---|---|
|
Get instant access to data, Sign up for free 
FY 2025
|
$321.33 B |
$27.37 B
9.31%
|
| Q4: Sep 25 | $83.73 B |
$4.68 B
5.92%
|
| Q3: Jun 25 | $80.66 B |
$6.42 B
8.65%
|
| Q2: Mar 25 | $75.45 B |
$7.04 B
10.29%
|
| Q1: Dec 24 | $81.49 B |
$9.23 B
12.78%
|
|
Get instant access to data, Sign up for free
FY 2024
|
$293.96 B |
$31.79 B
12.12%
|
| Q4: Sep 24 | $79.05 B |
$10.13 B
14.69%
|
| Q3: Jun 24 | $74.24 B |
$7.29 B
10.9%
|
| Q2: Mar 24 | $68.41 B |
$4.96 B
7.81%
|
| Q1: Dec 23 | $72.25 B |
$9.41 B
14.97%
|
|
Get instant access to data, Sign up for free
FY 2023
|
$262.17 B |
$23.59 B
9.89%
|
| Q4: Sep 23 | $68.92 B |
$7.75 B
12.67%
|
| Q3: Jun 23 | $66.95 B |
$6.88 B
11.46%
|
| Q2: Mar 23 | $63.46 B |
$5.74 B
9.94%
|
| Q1: Dec 22 | $62.85 B |
$3.22 B
5.4%
|
|
Get instant access to data, Sign up for free
FY 2022
|
$238.59 B |
$24.60 B
11.5%
|
| Q4: Sep 22 | $61.17 B |
$2.26 B
3.84%
|
| Q3: Jun 22 | $60.06 B |
$6.66 B
12.47%
|
| Q2: Mar 22 | $57.72 B |
$8.57 B
17.43%
|
| Q1: Dec 21 | $59.63 B |
$7.11 B
13.54%
|
|
Get instant access to data, Sign up for free
FY 2021
|
$213.99 B |
$24.09 B
12.69%
|
| Q4: Sep 21 | $58.91 B |
$9.67 B
19.63%
|
| Q3: Jun 21 | $53.41 B |
$8.04 B
17.72%
|
| Q2: Mar 21 | $49.15 B |
$1.74 B
3.66%
|
| Q1: Dec 20 | $52.52 B |
$4.65 B
9.72%
|
|
Get instant access to data, Sign up for free
FY 2020
|
$189.89 B |
$10.30 B
5.74%
|
| Q4: Sep 20 | $49.24 B |
$3.61 B
7.9%
|
| Q3: Jun 20 | $45.37 B |
$127.51 M
0.28%
|
| Q2: Mar 20 | $47.42 B |
$4.10 B
9.46%
|
| Q1: Dec 19 | $47.86 B |
$2.47 B
5.45%
|
|
Get instant access to data, Sign up for free
FY 2019
|
$179.59 B |
$11.65 B
6.94%
|
| Q4: Sep 19 | $45.64 B |
$2.34 B
5.41%
|
| Q3: Jun 19 | $45.24 B |
$2.10 B
4.86%
|
| Q2: Mar 19 | $43.32 B |
$2.29 B
5.57%
|
| Q1: Dec 18 | $45.39 B |
$4.93 B
12.17%
|
|
Get instant access to data, Sign up for free
FY 2018
|
$167.94 B |
$14.80 B
9.66%
|
| Q4: Sep 18 | $43.30 B |
$4.18 B
10.68%
|
| Q3: Jun 18 | $43.14 B |
$4.44 B
11.46%
|
| Q2: Mar 18 | $41.03 B |
$3.89 B
10.46%
|
| Q1: Dec 17 | $40.47 B |
$2.30 B
6.02%
|
|
Get instant access to data, Sign up for free
FY 2017
|
$153.14 B |
$6.29 B
4.29%
|
| Q4: Sep 17 | $39.12 B |
$1.56 B
4.15%
|
| Q3: Jun 17 | $38.71 B |
$1.83 B
4.95%
|
| Q2: Mar 17 | $37.15 B |
$1.45 B
4.06%
|
| Q1: Dec 16 | $38.17 B |
$1.46 B
3.98%
|
|
Get instant access to data, Sign up for free
FY 2016
|
$146.85 B |
$10.89 B
8.01%
|
| Q4: Sep 16 | $37.56 B |
$2.09 B
5.89%
|
| Q3: Jun 16 | $36.88 B |
$2.65 B
7.74%
|
| Q2: Mar 16 | $35.70 B |
$3.03 B
9.27%
|
| Q1: Dec 15 | $36.71 B |
$3.12 B
9.29%
|
Agilent Technologies Revenue
Eli Lilly and Company Revenue
Stryker Corporation Revenue
Johnson & Johnson Revenue
AbbVie Revenue
Merck & Co. Revenue
Thermo Fisher Scientific Revenue
Abbott Laboratories Revenue
Danaher Corporation Revenue
